Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11858907 Kinase modulators

Patent 11858907 was granted and assigned to Rhizen Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Rhizen Pharmaceuticals
Rhizen Pharmaceuticals
0
Date Filed
August 30, 2019
0
Date of Patent
January 2, 2024
0
Patent Application Number
16557553
0
Patent Citations
‌
US Patent 7589101 Compounds and compositions as protein kinase inhibitors
0
‌
US Patent 7592342 Quinoxaline derivatives as PI3 kinase inhibitors
0
‌
US Patent 7595320 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof
0
‌
US Patent 7595330 Benzimidazole thiophene compounds
0
‌
US Patent 7598245 Aminotriazole compounds useful as inhibitors of protein kinases
0
‌
US Patent 7601718 Compositions useful as inhibitors of protein kinases
0
‌
US Patent 7601724 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
0
‌
US Patent 7605155 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
0
‌
US Patent 7605160 Pyrrolotriazine kinase inhibitors
0
‌
US Patent 7608622 Imidazo[4,5-
0
•••
Patent Inventor Names
Swaroop K. Vakkalanka
0
Govindarajulu Babu
0
Srikant Viswanadha
0
Meyyappan Muthuppalaniappan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11858907
0
Patent Primary Examiner
‌
Brian E McDowell
0
CPC Code
‌
C07D 519/00
0
‌
C07D 311/34
0

Find more entities like US Patent 11858907 Kinase modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo